Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Non-Current Debt: 2010-2012

Historic Non-Current Debt for Anika Therapeutics (ANIK) over the last 3 years, with Dec 2012 value amounting to $8.0 million.

  • Anika Therapeutics' Non-Current Debt was N/A to $25.0 million in Q3 2020 from the same period last year, while for Sep 2020 it was $25.0 million, marking a year-over-year change of. This contributed to the annual value of $8.0 million for FY2012, which is 16.67% down from last year.
  • Anika Therapeutics' Non-Current Debt amounted to $8.0 million in FY2012, which was down 16.67% from $9.6 million recorded in FY2011.
  • In the past 5 years, Anika Therapeutics' Non-Current Debt registered a high of $11.2 million during FY2010, and its lowest value of $8.0 million during FY2012.
  • Moreover, its 3-year median value for Non-Current Debt was $9.6 million (2011), whereas its average is $9.6 million.
  • Data for Anika Therapeutics' Non-Current Debt shows a maximum YoY declined of 16.67% (in 2012) over the last 5 years.
  • Over the past 3 years, Anika Therapeutics' Non-Current Debt (Yearly) stood at $11.2 million in 2010, then dropped by 14.29% to $9.6 million in 2011, then decreased by 16.67% to $8.0 million in 2012.